These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 31206803)

  • 21. Dissection and design of yeast prions.
    Osherovich LZ; Cox BS; Tuite MF; Weissman JS
    PLoS Biol; 2004 Apr; 2(4):E86. PubMed ID: 15045026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based view on [PSI(+)] prion properties.
    Bondarev SA; Zhouravleva GA; Belousov MV; Kajava AV
    Prion; 2015; 9(3):190-9. PubMed ID: 26030475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity and infectivity: insights from de novo prion formation.
    Wisniewski BT; Sharma J; Legan ER; Paulson E; Merrill SJ; Manogaran AL
    Curr Genet; 2018 Feb; 64(1):117-123. PubMed ID: 28856415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity-enhanced NMR reveals alterations in protein structure by cellular milieus.
    Frederick KK; Michaelis VK; Corzilius B; Ong TC; Jacavone AC; Griffin RG; Lindquist S
    Cell; 2015 Oct; 163(3):620-8. PubMed ID: 26456111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-binding and prion domains: the Yin and Yang of phase separation.
    Gotor NL; Armaos A; Calloni G; Torrent Burgas M; Vabulas RM; De Groot NS; Tartaglia GG
    Nucleic Acids Res; 2020 Sep; 48(17):9491-9504. PubMed ID: 32857852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of amyloid aggregate sizes with semi-denaturing detergent agarose gel electrophoresis and its limitations.
    Drozdova PB; Barbitoff YA; Belousov MV; Skitchenko RK; Rogoza TM; Leclercq JY; Kajava AV; Matveenko AG; Zhouravleva GA; Bondarev SA
    Prion; 2020 Dec; 14(1):118-128. PubMed ID: 32306832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The three faces of Sup35.
    Lyke DR; Dorweiler JE; Manogaran AL
    Yeast; 2019 Aug; 36(8):465-472. PubMed ID: 30963611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sup35p in Its Soluble and Prion States Is Packaged inside Extracellular Vesicles.
    Kabani M; Melki R
    mBio; 2015 Aug; 6(4):. PubMed ID: 26286691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role for the proteasome in the turnover of Sup35p and in [PSI(+) ] prion propagation.
    Kabani M; Redeker V; Melki R
    Mol Microbiol; 2014 May; 92(3):507-28. PubMed ID: 24589377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mutation within the C-terminal domain of Sup35p that affects [PSI+] prion propagation.
    Kabani M; Cosnier B; Bousset L; Rousset JP; Melki R; Fabret C
    Mol Microbiol; 2011 Aug; 81(3):640-58. PubMed ID: 21631606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles-Encapsulated Yeast Prions and What They Can Tell Us about the Physical Nature of Propagons.
    Kabani M
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth phase-dependent changes in the size and infectivity of SDS-resistant Sup35p assemblies associated with the [PSI
    Wang K; Melki R; Kabani M
    Mol Microbiol; 2019 Sep; 112(3):932-943. PubMed ID: 31206803
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.